Beckley Psytech To Evaluate Psilocybin In A Rare Debilitating Headache
VC-Backed Biotech To Target SUNHA
The effect of low-dose psilocybin, a compound found in mushrooms, on a rare debilitating condition, short-lasting unilateral neuralgiform headaches attacks, is to be evaluated by the 2019-founded UK biotech, Beckley Psytech.
